Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics.

mBio - 20 Jan 2015

Kugelman Jeffrey R, Sanchez-Lockhart Mariano, Andersen Kristian G, Gire Stephen, Park Daniel J, Sealfon Rachel, Lin Aaron E, Wohl Shirlee, Sabeti Pardis C, Kuhn Jens H, Palacios Gustavo F

Abstract excerpt

Until recently, Ebola virus (EBOV) was a rarely encountered human pathogen that caused disease among small populations with extraordinarily high lethality. At the end of 2013, EBOV initiated an unprecedented disease outbreak in West Africa that is still ongoing and has already caused thousands of deaths. Recent studies revealed the genomic changes this particular EBOV variant undergoes over time during...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Ebolavirus
Share to Genetic Variation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genomics

Share to Hemorrhagic Fever, Ebola

Share to Mutation

Share to RNA, Small Interfering

Share to Viral Infections and Outbreaks Research

Share to Viral Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 25604787
DOI: 10.1128/mBio.02227-14
PMCID: PMC4313914

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of the potential impact of Ebola virus genomic drift on the efficacy of sequence-based candidate therapeutics.PMID 25604787Read ↗

Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino OligomersSemantic proximity Read ↗

Expanding the watch list for potential Ebola virus antibody escape mutationsSemantic proximity Read ↗

A Single Phosphorodiamidate Morpholino Oligomer Targeting VP24 Protects Rhesus Monkeys against Lethal Ebola Virus InfectionSemantic proximity Read ↗

Determination and Therapeutic Exploitation of Ebola Virus Spontaneous Mutation Frequency.Semantic proximity Read ↗

Reversion of Ebolavirus Disease from a Single Intramuscular Injection of a pan-Ebolavirus ImmunotherapeuticSemantic proximity Read ↗

Integrated technology platform for accelerated discovery of antiviral antibody therapeuticsSemantic proximity Read ↗

Discovery and Early Development of AVI-7537 and AVI-7288 for the Treatment of Ebola Virus and Marburg Virus InfectionsSemantic proximity Read ↗

Monotherapy with antibody 1C3 partially protects Ebola virus-exposed macaques.Semantic proximity Read ↗

Preliminary Evaluation of the Effect of Investigational Ebola Virus Disease Treatments on Viral Genome Sequences.Semantic proximity Read ↗

In Vivo Delivery of Synthetic Human DNA-Encoded Monoclonal Antibodies Protect against Ebolavirus Infection in a Mouse ModelSemantic proximity Read ↗

Human antibody cocktail deploys multiple functions to confer pan-ebolavirus protectionSemantic proximity Read ↗

Molecular modeling and simulation studies of SELEX-derived high-affinity DNA aptamers to the Ebola virus nucleoproteinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.